These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21271167)

  • 1. [Morphological and physiological analysis of livers and kidneys of pregnant rats and their fetuses treated by the association of zidovudine, lamivudine and ritonavir for the whole period of pregnancy].
    Wagner A; de Carvalho AM; Nakamura MU; Simões RS; Fontes TM; Espiridião S; Kulay Júnior L
    Rev Bras Ginecol Obstet; 2010 Nov; 32(11):556-62. PubMed ID: 21271167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the association zidovudine plus ritonavir on the liver and kidneys of pregnant rats. Morphological and biochemical aspects.
    Fontes TM; Nakamura MU; Mattar R; Simões RS; Wagner A; de Carvalho AM; Espiridião S; Kulay L
    Clin Exp Obstet Gynecol; 2011; 38(2):126-30. PubMed ID: 21793271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined zidovudine/lopinavir/ritonavir therapy during rat pregnancy: morphological aspects.
    de Carvalho LP; Simões RS; Wagner A; Tavella JS; Oliveira-Filho RM; Kulay L; Nakamura MU
    Clin Exp Obstet Gynecol; 2013; 40(3):345-9. PubMed ID: 24283162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lopinavir-ritonavir combined therapy during the rat pregnancy. Morphological and biochemical aspects.
    Cunha AM; Hagemann CC; Simões RS; Oliveira-Filho RM; Simões MJ; Soares JM; Maciel GA; Oliveira FH; Amed AA; Kulay L
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):60-3. PubMed ID: 16989938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic action of lamivudine and ritonavir on maternal and fetal liver and kidney of albino pregnant rats (Rattus norvegicus albinus, Rodentia, Mammalia): morphological and biochemical aspects.
    Vangelotti AM; Araujo Júnior E; Simões J; Amed AM; Nakamura MU; Júnior LK
    Clin Exp Obstet Gynecol; 2015; 42(4):523-8. PubMed ID: 26411225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A morphological and biochemical appraisal of the liver and renal effects of lamivudine on rat pregnancy.
    Pontes RD; Amed AM; Simões RS; Oliveira-Filho RM; Simões MJ; Kulay LJ
    Clin Exp Obstet Gynecol; 2006; 33(4):209-12. PubMed ID: 17211966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biochemical appraisal of the liver and renal effects of indinavir on rat pregnancy.
    Quintino MP; Simões RS; Oliveira FH; Oliveira-Filho RM; Simões MJ; Nakamura MU; Kulay L
    Clin Exp Obstet Gynecol; 2007; 34(4):232-5. PubMed ID: 18225685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic stavudine exposure on liver, pancreas and kidneys of pregnant rats and their fetuses: morphological and biochemical aspects.
    Barreto RL; Soares JM; Simões RS; Maciel GA; Simões Mde J; Kulay L
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):50-3. PubMed ID: 16530920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of daily intake of zidovudine-stavudine on rat pregnancy outcome: biological essay.
    Restum Antonio E; Pereira Fontes TM; Simões RS; Moreira de Carvalho A; Espiridião S; Uchiyama Nakamurau M; Kulay L
    Clin Exp Obstet Gynecol; 2012; 39(2):205-8. PubMed ID: 22905465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic action of association of zidovudine, lamivudine and ritonavir on pregnant rats. A biologic assay.
    Wagner A; Nakamura MU; Simões RS; Oliveira-Filho RM; Fontes TM; de Carvalho LP; Espiridiao S; Kulay L
    Clin Exp Obstet Gynecol; 2011; 38(1):28-32. PubMed ID: 21485721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended administration of the association of zidovudine plus ritonavir during rat pregnancy: maternal and fetal effects.
    Pereira Fontes TM; Santos Simões R; Martins Oliveira FH; de Jesus Simões Ms; Oliveira-Filho RM; Nakamura MU; Kulay L
    Clin Exp Obstet Gynecol; 2007; 34(3):175-8. PubMed ID: 17937095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of nelfinavir use during pregnancy. An experimental approach in rats.
    Mathias CV; Mathias CF; Simões MJ; Amed AM; Simões RS; Oliveira-Filho RM; Kulay L
    Clin Exp Obstet Gynecol; 2005; 32(3):163-5. PubMed ID: 16433154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of lopinavir/ritonavir association during rat pregnancy: maternal and fetal effects.
    Kulay L; Hagemann CC; Nakamura MU; Simões RS; de Carvalho AM; Oliveira-Filho RM; Espiridião S
    Clin Exp Obstet Gynecol; 2013; 40(1):151-4. PubMed ID: 23724532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
    Feeney ER; van Vonderen MG; Wit F; Danner SA; van Agtmael MA; Villarroya F; Domingo P; Capeau J; Reiss P; Mallon PW;
    AIDS; 2012 Nov; 26(17):2165-74. PubMed ID: 22874517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice.
    Venerosi A; Valanzano A; Alleva E; Calamandrei G
    Teratology; 2001 Jan; 63(1):26-37. PubMed ID: 11169552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometrical evaluation of fetuses and newborns kidneys status developing under maternal iron deficiency anemaia conditions].
    Sorokina IV; Myroshnychenko MS; Kapustnyk NV; Simachova AV; Ivanova AA
    Wiad Lek; 2018; 71(7):1222-1230. PubMed ID: 30448788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of daily administration of a stavudine/nelfinavir association on the fetuses and placentas of female albino rats].
    de Carvalho GM; Nakamura MU; Simões RS; Antonio EM; Wagngner A; Fontes TM; Kulay Júnior L
    Rev Bras Ginecol Obstet; 2011 May; 33(5):225-30. PubMed ID: 21860929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection.
    Rabaud C; Burty C; Grandidier M; Christian B; Penalba C; Béguinot I; Jeanmaire H; May T
    Clin Infect Dis; 2005 Jan; 40(2):303-5. PubMed ID: 15655751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
    J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects.
    Huang F; Allen L; Huang DB; Moy F; Vinisko R; Nguyen T; Rowland L; MacGregor TR; Castles MA; Robinson P
    J Clin Pharm Ther; 2012 Feb; 37(1):81-8. PubMed ID: 21128991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.